|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
52894110
線上人數 :
780
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"hung y p"的相關文件
顯示項目 21-30 / 284 (共29頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2022 |
COVID-19-associated candidiasis and the emerging concern of Candida auris infections
|
Tsai, C.-S.;Lee, S.S.-J.;Chen, W.-C.;Tseng, C.-H.;Lee, N.-Y.;Chen, P.-L.;Li, M.-C.;Syue, L.-S.;Lo, C.-L.;Ko, W.-C.;Hung, Y.-P. |
| 臺大學術典藏 |
2021-09-14T02:45:52Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; JHONG-LIN WU; Tseng W.-P.; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-09-02T00:04:56Z |
Quantitative spectroscopic comparison of the optical properties of mouse cochlea microstructures using optical coherence tomography at 1.06 μm and 1.3 μm wavelengths
|
Tsa T.-Y;Chen T.-H;Chen H.-C;Chueh C.-B;Huang Y.-P;Hung Y.-P;Tsai M.-T;Baumann B;Wang C.-H;Lee H.-C.; Tsa T.-Y; Chen T.-H; Chen H.-C; Chueh C.-B; Huang Y.-P; Hung Y.-P; Tsai M.-T; Baumann B; Wang C.-H; Lee H.-C.; HSIANG-CHIEH LEE |
| 臺大學術典藏 |
2021-08-31T06:29:21Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:15Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; ANN-LII CHENG; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2021-08-18T07:39:05Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; JHE-CYUAN GUO; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:34Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
ZHONG-ZHE LIN; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2021-08-03T07:10:54Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; YU-YUN SHAO; Lee J.-M.; Hsu C.; Hsu C.-H.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-08-03T07:10:52Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; YU-YUN SHAO; Hsu C.; Hsu C.-H.; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-06-03T06:15:37Z |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
|
Chou W.-C.; PO-HAN LIN; Yeh Y.-C.; Shyr Y.-M.; Fang W.-L.; Wang S.-E.; Liu C.-Y.; Chang P.M.-H.; Chen M.-H.; Hung Y.-P.; Li C.-P.; Chao Y.; Chen M.-H. |
顯示項目 21-30 / 284 (共29頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
